相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis
Marcus Ruscetti et al.
CANCER RESEARCH (2015)
BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence
Lei Gu et al.
NATURE GENETICS (2015)
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
Rhonda L. Bitting et al.
CANCER AND METASTASIS REVIEWS (2014)
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
Mercedes Marin-Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2014)
A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
David J. Konieczkowski et al.
CANCER DISCOVERY (2014)
A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
Dana E. Rathkopf et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
N of 1 case reports in the era of whole-genome sequencing
A. Rose Brannon et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Tracking the clonal origin of lethal prostate cancer
Michael C. Haffner et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
Wai Leong Tam et al.
NATURE MEDICINE (2013)
HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
Miao Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
Taru Muranen et al.
CANCER CELL (2012)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
David J. Mulholland et al.
CANCER RESEARCH (2012)
New Perspectives in the Therapy of Castration Resistant Prostate Cancer
Pasquale Rescigno et al.
CURRENT DRUG TARGETS (2012)
Genome-wide analysis of HMGA2 transcription factor binding sites by ChIP on chip in gastric carcinoma cells
Lang Zha et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling
Yang Zong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The genomic landscape of prostate cancer
Sylvan C. Baca et al.
Frontiers in Endocrinology (2012)
Histone deacetylase regulates high mobility group A2-targeting microRNAs in human cord blood-derived multipotent stem cell aging
Seunghee Lee et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Translating Scientific Advancement into Clinical Benefit for Castration-Resistant Prostate Cancer Patients
Gerhardt Attard et al.
CLINICAL CANCER RESEARCH (2011)
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
Andrew J. Armstrong et al.
MOLECULAR CANCER RESEARCH (2011)
Suppression of lung adenocarcinoma progression by Nkx2-1
Monte M. Winslow et al.
NATURE (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
L. R. Molife et al.
ANNALS OF ONCOLOGY (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer
Dana Rathkopf et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
Hiroshi Tanaka et al.
NATURE MEDICINE (2010)
HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells
Sugiko Watanabe et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Vorinostat in Advanced Prostate Cancer Patients Progressing on Prior Chemotherapy (National Cancer Institute Trial 6862) Trial Results and Interleukin-6 Analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium
Deborah Bradley et al.
CANCER (2009)
Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer
Derek S. Welsbie et al.
CANCER RESEARCH (2009)
Lin-Sca-1+CD49fhigh Stem/Progenitors Are Tumor-Initiating Cells in the Pten-Null Prostate Cancer Model
David J. Mulholland et al.
CANCER RESEARCH (2009)
Hmga2 Promotes Neural Stem Cell Self-Renewal in Young but Not Old Mice by Reducing p16Ink4a and p19Arf Expression
Jinsuke Nishino et al.
CELL (2008)
The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor
Annemie Haelens et al.
CANCER RESEARCH (2007)
High-level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells
Ou Li et al.
GENESIS (2006)
NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss
Qunying Lei et al.
CANCER CELL (2006)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo
JY Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program
RB Shah et al.
CANCER RESEARCH (2004)
Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth
MF Fu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
SY Wang et al.
CANCER CELL (2003)
Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene
M Ferguson et al.
NUCLEIC ACIDS RESEARCH (2003)
Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer
C Langelotz et al.
BRITISH JOURNAL OF CANCER (2003)
Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor.
L Gaughan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
